IRF5 抗体
(Interferon Regulatory Factor 5 (IRF5))
This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Multiple transcript variants encoding different isoforms have been found for this gene, and a 30-nt indel polymorphism (SNP rs60344245) can result in loss of a 10-aa segment. [provided by RefSeq, Mar 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| IRF5 抗体 (AA 395-504) | 人 | 小鼠 Monoclonal |
|
|
|
| IRF5 抗体 (AA 395-504) | 人 | 小鼠 Monoclonal |
|
|
|
| IRF5 抗体 (C-Term) | 人 | 山羊 Polyclonal |
|
|
|
| IRF5 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 1-200) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 214-395) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 176-240) | 人 | 小鼠 Monoclonal |
|
|
|
| IRF5 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 1-498) | 人 | 小鼠 Monoclonal |
|
|
|
| IRF5 抗体 (AA 81-108) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant IRF5 抗体 (N-Term) | 人 | 兔 Monoclonal |
|
|
|
| IRF5 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 176-240) | 人 | 小鼠 Monoclonal |
|
|
|
| IRF5 抗体 | 人 | 兔 Monoclonal |
|
|
|
| IRF5 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (pSer446) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 3-250) | 小鼠 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 1-498) | 人 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 395-444) | 人, 小鼠, 大鼠, Cow, Pig, 兔, 马, 犬, 猴, 斑马鱼 | 兔 Polyclonal |
|
|
|
| IRF5 抗体 (AA 121-170) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1H6
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 395-504
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2D4
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 395-504
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 质量等级
- Verified
- 适用
- 人
- 宿主
- 山羊
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-200
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 214-395
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10T1
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 176-240
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB17419
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 81-108, N-Term
Primary Antibody
- ELISA (ELISA: 有验证图片)
- WB (Western Blotting: 有验证图片)
- ISt (Immunostaining: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 2G9
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-498
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 81-108
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ChIP-seq (ChIP DNA-Sequencing: 有验证图片)
- ChIP (Chromatin Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 10T1
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 抗原表位
- AA 176-240
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- C-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF/ICC (Immunofluorescence (fixed cells): 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- pSer446
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 3-250
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-498
Latest Publications for our IRF5 抗体
: "Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients. ..." in: Frontiers in immunology, Vol. 10, pp. 1029, (2019) (PubMed).
: "Interferon regulatory factor 4/5 signaling impacts on microglial activation after ischemic stroke in mice." in: The European journal of neuroscience, Vol. 47, Issue 2, pp. 140-149, (2018) (PubMed).
: "Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality." in: Scientific reports, Vol. 6, pp. 31002, (2016) (PubMed).
: "MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection." in: PLoS ONE, Vol. 7, Issue 8, pp. e42476, (2012) (PubMed).
: "Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis." in: Breast cancer research : BCR, Vol. 13, Issue 6, pp. R111, (2012) (PubMed).
: "IRF5 is required for late-phase TNF secretion by human dendritic cells." in: Blood, Vol. 115, Issue 22, pp. 4421-30, (2010) (PubMed).
: "IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway." in: The Journal of biological chemistry, Vol. 284, Issue 5, pp. 2767-77, (2009) (PubMed).
: "Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF." in: European journal of heart failure, Vol. 10, Issue 12, pp. 1264-7, (2008) (PubMed).
: "Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus." in: Human molecular genetics, Vol. 17, Issue 6, pp. 872-81, (2008) (PubMed).
: "Methamphetamine enhances Hepatitis C virus replication in human hepatocytes." in: Journal of viral hepatitis, Vol. 15, Issue 4, pp. 261-70, (2008) (PubMed).
: "Interferon regulatory factor 4/5 signaling impacts on microglial activation after ischemic stroke in mice." in: The European journal of neuroscience, Vol. 47, Issue 2, pp. 140-149, (2018) (PubMed).
: "Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality." in: Scientific reports, Vol. 6, pp. 31002, (2016) (PubMed).
: "MyD88-dependent signaling influences fibrosis and alternative macrophage activation during Staphylococcus aureus biofilm infection." in: PLoS ONE, Vol. 7, Issue 8, pp. e42476, (2012) (PubMed).
: "Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis." in: Breast cancer research : BCR, Vol. 13, Issue 6, pp. R111, (2012) (PubMed).
: "IRF5 is required for late-phase TNF secretion by human dendritic cells." in: Blood, Vol. 115, Issue 22, pp. 4421-30, (2010) (PubMed).
: "IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway." in: The Journal of biological chemistry, Vol. 284, Issue 5, pp. 2767-77, (2009) (PubMed).
: "Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF." in: European journal of heart failure, Vol. 10, Issue 12, pp. 1264-7, (2008) (PubMed).
: "Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus." in: Human molecular genetics, Vol. 17, Issue 6, pp. 872-81, (2008) (PubMed).
: "Methamphetamine enhances Hepatitis C virus replication in human hepatocytes." in: Journal of viral hepatitis, Vol. 15, Issue 4, pp. 261-70, (2008) (PubMed).
Aliases for IRF5 抗体
interferon regulatory factor 5 (IRF5) 抗体interferon regulatory factor 5 (irf5) 抗体
interferon regulatory factor 5 (Irf5) 抗体
interferon regulatory factor 5 L homeolog (irf5.L) 抗体
AW491843 抗体
im:7155364 抗体
IRF5 抗体
irf5 抗体
mirf5 抗体
SLEB10 抗体
zgc:76986 抗体
您还需要查找其他产品吗？
You are here:
